INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 161 filers reported holding INSMED INC in Q3 2019. The put-call ratio across all filers is 2.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,051,000 | +45.8% | 470,741 | +65.6% | 10.04% | +0.1% |
| Q1 2019 | $8,264,000 | -24.9% | 284,263 | -66.1% | 10.03% | +121.0% |
| Q4 2018 | $11,007,000 | -23.8% | 838,946 | +17.5% | 4.54% | +64.0% |
| Q3 2018 | $14,440,000 | -5.6% | 714,159 | +10.4% | 2.77% | +16.8% |
| Q2 2018 | $15,298,000 | -26.0% | 646,863 | -29.6% | 2.37% | -30.4% |
| Q1 2018 | $20,685,000 | +33.0% | 918,523 | +84.1% | 3.41% | +18.8% |
| Q4 2017 | $15,556,000 | +246.2% | 498,921 | +246.5% | 2.87% | +148.1% |
| Q3 2017 | $4,494,000 | +63.7% | 144,000 | -10.0% | 1.16% | -3.3% |
| Q2 2017 | $2,746,000 | -35.6% | 160,000 | -50.3% | 1.20% | -52.1% |
| Q4 2016 | $4,261,000 | -8.9% | 322,044 | 0.0% | 2.50% | -13.1% |
| Q3 2016 | $4,676,000 | +181.2% | 322,044 | +90.9% | 2.87% | +99.5% |
| Q2 2016 | $1,663,000 | +228.0% | 168,700 | +321.8% | 1.44% | +174.3% |
| Q1 2016 | $507,000 | – | 40,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |